Pacific Biosciences Of California (PACB) Treasury Shares (2018 - 2026)

Pacific Biosciences Of California has reported Treasury Shares for 9 years, with the latest figure at $19.2 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 4804.59% year-over-year to $19.2 million; the trailing twelve-month figure through Mar 2026 stood at $19.2 million (up 4804.59% YoY), and the FY2025 full-year result was $392000.0, changed 0.0% from the prior year.
• Treasury Shares for Q1 2026 stood at $19.2 million, up from $392000.0 in the prior quarter.
• The five-year high for Treasury Shares was $19.2 million in Q1 2026, with the low at $8392.0 in Q2 2022.
• Average Treasury Shares over 5 years is $8.4 million, with a median of $8.8 million recorded in 2022.
• Year-over-year, Treasury Shares tumbled 99.88% in 2022 and soared 150555.39% in 2023.
• Tracing PACB's Treasury Shares over 5 years: stood at $8.7 million in 2022, then sank by 93.76% to $541000.0 in 2023, then slipped by 27.54% to $392000.0 in 2024, then changed by 0.0% to $392000.0 in 2025, then soared by 4804.59% to $19.2 million in 2026.
• The last three Treasury Shares figures came in at $19.2 million (Q1 2026), $392000.0 (Q4 2025), and $18.1 million (Q3 2025), per Business Quant data.

Peer Comparison